Vivimed Labs Limited has informed the Exchange regarding 'ResultsH12026'.
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivimed Labs Limited has submitted its half-yearly financial results for the period ending September 2025 (H1 FY2026) to the stock exchange. The filing is a standard regulatory disclosure informing the exchange that the results have been filed, but the specific revenue, profit, margin, and balance sheet figures are not included in this notification. Investors will need to refer to the detailed results document for actual numbers and year-on-year comparisons. No auditor remarks, exceptional items, or material observations were indicated in the filing notification.
This is a routine compliance filing with no immediate price-moving information. Shareholders should review the accompanying detailed results for revenue trends, profitability, and any auditor qualifications before drawing conclusions.